RESEARCH

Phase 3 Trial

A Phase 3 open- label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)

Principal Investigator
Patrick Nachman, MD

Co-Investigators
Andrew Johnson, MD
Nattawat Klomjit, MD
Sahar Koubar, MBBS
Aahd Kubbara, MD
Katie Pendleton, MD
Sami Safadi, MD

Study Coordinator
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL

Systolic Blood Pressure Intervention Trial (SPRINT)
Blood Pressure and Kidney Function - SPRINT vs Electronic Health Record Data 

Principal Investigator
Paul Drawz, MD

Program Manager
Nayanjot Kaur Rai, MPH, BDS | rai00041@umn.edu

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator:
Patrick Nachman, MD

Co-Principal Investigators: 
Michelle Rheault, MD
Angie Lobo, MD

Study Coordinators: 
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

New Study Starting Soon!

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.

Principal Investigator
Sahar Koubar, MBBS

Co-Investigators
Nattawat Klomjit, MD 
Patrick H. Nachman, MD

Study Coordinator:
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

New Study Starting Soon!

Phase 2 Trial

Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (REBOOT)

Principal Investigator
Patrick Nachman, MD

Co-Investigator
Surabhi Thakar, MD
Katti Woerner, MD

Study Coordinators
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator: 
Patrick Nachman, MD

Co-Principal Investigators: 
Michelle Rheault, MD
Angie Lobo, MD

Study Coordinators: 
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

The Nephrotic Syndrome Study Network (NEPTUNE)

Principal Investigator
Patrick Nachman, MD

Co-Principal Investigator
Angie Lobo, MD
Michelle Rheault, MD

Study Coordinators
Scott Rajala, CCRP | srajala@umn.edu
Nicolas Rauwolf | rauwo004@umn.edu

CLINICAL TRIAL

New Study Starting Soon!

New Study Starting Soon!

Kidney Precision Medicine Project (KPMP)

Co-Principal Investigators: 
Patrick Nachman, MD
Luiza Caramori, MD

Co-Investigators:
Oyedele Adeyi, MD
Yanli Ding, MD, PhD
Paul Drawz, MD, MHS, MS
Siobhan Flanagan, MD
Tasma Harindhanavudhi, MD, MS
Christopher Jones, MD
Sami Safadi, MD
Susan Wolf, JD

Study Coordinators: 
Nicolas Rauwolf | rauwo004@umn.edu
Michelle Snyder | snyde003@umn.edu
MinnKPMP@umn.edu

CLINICAL TRIAL About KPMP

To provide patients with systemic inflammatory disease or vasculitis with cutting-edge, individualized, comprehensive and integrated multidisciplinary care and access to clinical trials.

Learn More

To provide patients with glomerular disease with expert, individualized care and access to clinical trials.

Learn More